NEW DELHI : The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin.Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS told ANI that the hospital will start enrolling healthy individuals from Monday onwards."Today, we got approval from AIIMS Ethics Committee for starting the human clinical trial of the indigenously developed Covaxin.
We are launching the enrollment process from Monday. We are going to select healthy participants with no comorbidities and without a history of COVID-19.